LTR Pharma Completes Extractables Study Milestone for SPONTAN®
LTR Pharma has completed extractables studies for SPONTAN®, its intranasal spray for erectile dysfunction, with co-development partner Aptar Pharma. All identified compounds were confirmed below
Conversation Series | Lifestyle Factors and Erectile Dysfunction with Melissa Hadley Barrett
In the third episode of our Conversation Series, Sexologist and Nurse Practitioner, Melissa Hadley Barrett reveals the surprising lifestyle factors that significantly impact men’s sexual
Distinguished Urological Expert Joins LTR Pharma’s Scientific Advisory Board
LTR Pharma is pleased to announce that Clinical Associate Professor Darren Katz, a renowned urological surgeon and Medical Director of Men’s Health Melbourne, has joined
SPONTAN® Now Available at TerryWhite Chemmart Pharmacies Nationwide
LTR Pharma is pleased to announce that SPONTAN® is now available through TerryWhite Chemmart’s network of 600+ pharmacies nationwide, marking a pivotal milestone in our
LTR Pharma Signs Collaborative Development Agreement to Develop a Novel Intranasal Spray for Oesophageal Motility Disorders
LTR Pharma has announced that it has entered into a collaborative development agreement with Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal
Conversation Series | Patient Perspectives | Meet Steve Jones
In our latest Conversation Series video, we meet Steve Jones – a prostate cancer survivor whose candid story highlights the profound psychological impact of erectile